Impact of steroids and steroid-sparing agents on quality of life in children with nephrotic syndrome
Shawn Khullar(Royal College of Surgeons in Ireland), Rulan S. Parekh(Women's College Hospital), Jovanka Vasilevska‐Ristovska(Institute for Clinical Evaluative Sciences), Michele Reddon(Hospital for Sick Children), Damien Noone(Hospital for Sick Children), Josefina Brooke(Hospital for Sick Children), Rachel Pearl(University of Toronto), Rahul Chanchlani(McMaster Children's Hospital), Diane Hébert(University of Toronto), Valérie S. Langlois(Institut National de la Recherche Scientifique), Kim Aitken-Menezes(Hospital for Sick Children), Christoph Licht(University of Toronto), Monica Piekut(Hospital for Sick Children), Tonny Banh(Hospital for Sick Children), Seetha Radhakrishnan(University of Toronto)
Cited by 21
Related Papers
Identifying Individuals with Physcian Diagnosed COPD in Health Administrative Databases
|COPD Journal of Chronic Obstructive Pulmonary Disease|2009|664
MYH9 is associated with nondiabetic end-stage renal disease in African Americans
|Nature Genetics|2008|648
Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test
|Genetics in Medicine|2017|563
Identifying Patients with Physician‐Diagnosed Asthma in Health Administrative Databases
|Canadian Respiratory Journal|2009|439
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy
|Kidney International|2011|361